etoposide phosphate and Allergy, Drug

etoposide phosphate has been researched along with Allergy, Drug in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's2 (25.00)29.6817
2010's3 (37.50)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Gilbar, PJ; Grewal, GD; Pringle, NR1
Azmy, V; Brooks, JP; Hsu, FI; Luon, D; Price, C; Prozora, SD; Thompson, A1
Kokache, A; Mahmoud, S; Sambasivan, K; Savage, P; Seckl, M1
Bourneau-Martin, D; Drablier, G; Lagarce, L; Lainé-Cessac, P; Le Louet, H; Leguay, Z; Pellier, I1
Cirillo, M; O'Sullivan, M; Polistena, P; Purtill, D; Tran, Q1
Collier, K; How, K; Savage, P; Schink, C; Seckl, M; Young, AM1
Bernstein, BJ; Troner, MB1
De Boer, R; Desai, J; Prasad, P; Siderov, J1

Reviews

1 review(s) available for etoposide phosphate and Allergy, Drug

ArticleYear
Immediate severe hypersensitivity reaction to etoposide phosphate: Case report and review of the literature.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022, Volume: 28, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Hypersensitivity; Etoposide; Humans; Male; Organophosphorus Compounds; Young Adult

2022

Other Studies

7 other study(ies) available for etoposide phosphate and Allergy, Drug

ArticleYear
Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:1

    Topics: Adolescent; Bone Neoplasms; Drug Hypersensitivity; Etoposide; Humans; Male; Organophosphorus Compounds; Osteosarcoma; Sarcoma, Ewing

2020
Hypersensitivity reactions to etoposide phosphate.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2014, Volume: 20, Issue:2

    Topics: Adult; Antineoplastic Agents; Drug Hypersensitivity; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasms; Organophosphorus Compounds; Young Adult

2014
Successful Treatment with Etoposide Base after an Acute Hypersensitivity Reaction to Etoposide Phosphate.
    Pediatric blood & cancer, 2016, Volume: 63, Issue:3

    Topics: Acute Disease; Benzyl Alcohols; Carboplatin; Child, Preschool; Drug Hypersensitivity; Etoposide; Female; Humans; Infusions, Intravenous; Medulloblastoma; Organophosphorus Compounds

2016
Etoposide phosphate hypersensitivity overcome using a desensitisation programme enabling optimal therapy for relapsed Hodgkin lymphoma.
    Bone marrow transplantation, 2017, Volume: 52, Issue:3

    Topics: Adult; Desensitization, Immunologic; Drug Hypersensitivity; Etoposide; Hodgkin Disease; Humans; Male; Organophosphorus Compounds; Recurrence

2017
Successful treatment with etoposide phosphate in patients with previous etoposide hypersensitivity.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2008, Volume: 14, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Chlorpheniramine; Drug Hypersensitivity; Etoposide; Female; Humans; Hydrocortisone; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Organophosphorus Compounds

2008
Successful rechallenge with etoposide phosphate after an acute hypersensitivity reaction to etoposide.
    Pharmacotherapy, 1999, Volume: 19, Issue:8

    Topics: Adult; Antineoplastic Agents; Drug Hypersensitivity; Etoposide; Female; Humans; Organophosphorus Compounds

1999
Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide.
    British journal of cancer, 2002, Jan-07, Volume: 86, Issue:1

    Topics: Adult; Antineoplastic Agents; Drug Hypersensitivity; Etoposide; Humans; Infusions, Intravenous; Male; Organophosphorus Compounds

2002